Showing 9171-9180 of 18093 results for "".
- Advancements in Managing Transplant Complications: From GVHD to CRISPR Innovationshttps://reachmd.com/news/advancements-in-managing-transplant-complications-from-gvhd-to-crispr-innovations/2476112/Graft-Versus-Host Disease remains a challenging complication in solid organ transplantation, demanding nuanced strategies for management. Meanwhile, innovations like CRISPR promise to revolutionize how we approach post-transplant complications. Building on the pressi
- Revolutionizing IBD Management: The Rise of IL-23 Inhibitors and Cytokine Therapieshttps://reachmd.com/news/revolutionizing-ibd-management-the-rise-of-il-23-inhibitors-and-cytokine-therapies/2476124/Recent advances in cytokine-targeted therapies are transforming the treatment landscape for Crohn’s disease, offering new strategies to achieve durable remission. Crohn’s disease remains a relentless challenge within gastroenterology, marked by cyclical inflammation, mucosal damage,
- Revolutionizing Radiology: The Role of Advanced Imaging Techniques in Modern Diagnosticshttps://reachmd.com/news/revolutionizing-radiology-the-role-of-advanced-imaging-techniques-in-modern-diagnostics/2476126/Radiology is experiencing a revolution as advanced imaging techniques like Dual-Energy CT and 3D imaging transform how diseases are diagnosed and treated. In the midst of this technological progression, the ability to differentiate complex tissue structures with precision becomes in
- Improving Follow-Up: Addressing Gaps in Colonoscopy After Abnormal Cancer Screeningshttps://reachmd.com/news/improving-follow-up-addressing-gaps-in-colonoscopy-after-abnormal-cancer-screenings/2476108/Despite advancements in screening technologies, follow-up colonoscopies after abnormal stool-based tests remain insufficient, endangering patient outcomes, especially because the USPSTF recommends colonoscopy within one year of a positive fecal immunochemical test (FIT) result.
- Enhancing Brain Injury Outcomes: Integrating Noninvasive ICP Monitoring and AI-Driven Predictive Modelshttps://reachmd.com/news/enhancing-brain-injury-outcomes-integrating-noninvasive-icp-monitoring-and-ai-driven-predictive-models/2476114/Intracranial pressure (ICP) monitoring is an integral aspect of managing brain injury patients, yet the reliance on invasive techniques often poses significant risks. With innovations in noninvasive monitoring and AI-driven predictive models, the landscape of ICP management is under
- Navigating Mental Health Challenges in Incarcerated Youth: Insights and Innovationshttps://reachmd.com/news/navigating-mental-health-challenges-in-incarcerated-youth-insights-and-innovations/2476128/Incarcerated youth are navigating unprecedented mental health challenges and demanding strategic reforms to ensure fair and effective psychological care, especially as ongoing insights into adolescent brain development reshape our approach to risk assessment and intervention. As high
- Breaking New Ground in Sjögren’s Disease: The Success of Ianalumab Phase III Trialshttps://reachmd.com/news/breaking-new-ground-in-sjogrens-disease-the-success-of-ianalumab-phase-iii-trials/2476129/Recent developments, exemplified by the promising Phase III results of ianalumab, may signal a shift in the treatment landscape for Sjögren’s disease, although detailed peer‑reviewed data and regulatory review are still pending. In this context, symptoms like dry mouth and eyes stem
- The Evolution of Surgical Techniques in Endometrial Cancer: From Laparotomy to Innovationhttps://reachmd.com/news/the-evolution-of-surgical-techniques-in-endometrial-cancer-from-laparotomy-to-innovation/2476095/As surgical techniques for endometrial cancer continue reshaping oncologic practice, the move from open laparotomy toward minimally invasive surgery is forging a new era of precision and patient-centered care. Building on decades of open surgery, a landmark
- Frontline Immunity: Universal Vaccine Development Against Evolving Pathogenshttps://reachmd.com/news/frontline-immunity-universal-vaccine-development-against-evolving-pathogens/2476085/Frontline clinicians and infectious disease specialists face an onslaught of antigenically drifting viruses and novel zoonoses that outpace pathogen-specific defenses; universal vaccine development and integrated antiviral measures promise the broad-spectrum immunity needed to stay ahead of
- Molecular Interventions for Treatment-Resistant Nephrotic Syndrome Focus on cdc42https://reachmd.com/news/molecular-interventions-for-treatment-resistant-nephrotic-syndrome-focus-on-cdc42/2476083/Amid rising rates of treatment-resistant nephrotic syndrome, relentless proteinuria demands novel interventions—molecular targets like cdc42 now command attention for their potential to reshape therapy. Nephrologists often grapple with patients whose proteinuria persists despite maxi